Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Scapular Mobilization Added to Conventional Exercise in Ankylosing Spondylitis

13 de noviembre de 2026 actualizado por: Elif Umay Altas, Izmir Bakircay University

The Effect of Scapular Mobilization Added to Conventional Exercises on Respiratory Function, Posture, and Quality of Life in Patients With Ankylosing Spondylitis: A Randomized Controlled Trial

Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton that commonly leads to restricted spinal mobility, postural deformities such as thoracic hyperkyphosis, and reduced chest wall expansion, which can impair respiratory function and quality of life. Exercise is the cornerstone of rehabilitation in AS, and manual therapy techniques may provide additional benefit by restoring mobility of the thoracic cage and shoulder girdle.

The aim of this randomized controlled, single-blind trial is to investigate whether scapular mobilization added to a conventional exercise program improves chest expansion and respiratory function (primary outcomes), as well as pain, disease activity, function, spinal mobility, posture, exercise capacity, and quality of life (secondary outcomes) in patients with AS. Thirty-four patients will be randomly allocated to either scapular mobilization plus conventional exercise or conventional exercise alone, 3 sessions per week for 8 weeks (24 sessions). Outcomes will be assessed at baseline, after treatment (week 8), and at month 3.

Descripción general del estudio

Descripción detallada

Background: AS is a chronic inflammatory disease most frequently seen in young men, involving the spine, sacroiliac joints, peripheral joints, and entheses, and causing pain, stiffness, functional impairment, and postural abnormalities. Dysfunction of the thoracic spine and scapular region not only causes pain and limited movement but also restricts chest wall mobility, which may reduce ventilatory efficiency and quality of life. Previous studies have shown that thoracic mobilization exercises improve kyphosis and respiratory function (FVC, FEV1), aerobic exercise improves disease activity and respiratory muscle strength, and manual therapy added to exercise provides superior improvements in chest expansion and functional capacity. However, evidence on the specific added contribution of scapular mobilization to standard exercise programs is limited.

Design: Prospective, randomized, controlled, single-blind, parallel-group trial conducted at the Physical Medicine and Rehabilitation outpatient clinic of Izmir Bakircay University Cigli Training and Research Hospital.

Sample size: Based on Acharya et al. (2024), with an effect size of Cohen's d = 0.40, alpha = 0.05, power = 80%, a two-group repeated-measures design with three time points and a correlation of 0.3 between repeated measures, the minimum sample size is 30 (15 per group). Allowing for a 10% dropout rate, 34 participants (17 per group) will be enrolled.

Interventions: Both groups will receive the same progressive conventional exercise program (30 minutes per session, 3 sessions/week, 8 weeks, 24 sessions), supervised by the same physiotherapist. The experimental group will additionally receive approximately 20 minutes of scapular mobilization per session.

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Progression: Weeks 1-2 (initial level: movement learning, low-intensity mobility, breathing, stretching and low-resistance strengthening; 8-10 repetitions, 1-2 sets, slow tempo); weeks 3-5 (intermediate: increased repetitions and sets, dynamic movements, moderate elastic band resistance, breathing combined with arm movements; 10-15 repetitions, 2-3 sets, moderate tempo); weeks 6-8 (advanced: higher resistance, multi-joint functional movements, dynamic balance and coordination, increased aerobic duration; 12-15 repetitions, 3 sets, moderate-to-high tempo). Progression requires correct form, no increase in pain (VAS) during exercise, return of symptoms to baseline within 24 hours, and improved functional performance. Regression to the previous level occurs with increased pain, prolonged fatigue, postural deterioration, or compensatory movement patterns.

Scapular mobilization: Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Assessments: Demographic and clinical data (age, sex, height, weight, education, occupation, smoking/alcohol, family history, diagnosis year, symptom duration, medications and duration of use, extra-articular involvement, previous surgery, exercise habits) will be recorded. Outcome measures (VAS, BASDAI, BASFI, BASMI, ASQoL, chest expansion, spirometry, 6-minute walk test, thoracic kyphosis angle by digital inclinometer) will be assessed at baseline, after treatment (week 8), and at month 3.

Hypotheses: H0 - Scapular mobilization added to routine exercises has no effect on pain, posture, respiratory function, and quality of life in patients with AS. H1 - Scapular mobilization added to routine exercises has an effect on these parameters.

Statistical analysis: SPSS version 20.0 will be used, with p < 0.05 considered significant. Normality will be tested with the Kolmogorov-Smirnov test. Repeated-measures ANOVA will be used for parametric data; Friedman and Wilcoxon signed-rank tests for non-parametric data. Categorical variables will be compared using the chi-square test.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

34

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Izmir, Turquía (Türkiye), 35620
        • Izmir Bakircay University Cigli Training and Research Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

30 años a 60 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Diagnosis of ankylosing spondylitis according to the modified New York criteria
  • Age between 30 and 60 years
  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of 4.0 or lower
  • Pulmonary function test performed within the last month

Exclusion Criteria:

  • Regular exercise during the previous 3 months
  • Spinal ankylosis
  • Cardiovascular, pulmonary, orthopedic, or neurological conditions that may prevent exercise (uncontrolled hypertension, history of myocardial infarction or coronary revascularization, history of syncope or exercise-related arrhythmia, decompensated type 1 diabetes mellitus, history of hip and/or knee arthroplasty)
  • Any surgery within the last 6 months
  • Active disease flare within the last 3 months
  • Communication problems
  • Any other respiratory or neuromuscular disease that may affect the respiratory muscles

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Scapular Mobilization + Conventional Exercise

Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Otros nombres:
  • Maitland scapular mobilization

posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Otros nombres:
  • Standard exercise therapy
Comparador activo: Conventional Exercise

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Otros nombres:
  • Standard exercise therapy

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
Chest Expansion
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Forced Vital Capacity (FVC)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Forced Expiratory Volume in 1 Second (FEV1)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
FEV1/FVC Ratio
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3

Medidas de resultado secundarias

Medida de resultado
Periodo de tiempo
Peak Expiratory Flow (PEF)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Thoracic Pain Intensity (Visual Analog Scale)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Disease Activity (BASDAI)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Functional Status (BASFI)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Spinal Mobility (BASMI)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Quality of Life (ASQoL)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Thoracic Kyphosis Angle
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Functional Exercise Capacity (6-Minute Walk Test)
Periodo de tiempo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Elif Umay Altaş, Izmir Bakircay University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

16 de noviembre de 2026

Finalización primaria (Estimado)

16 de noviembre de 2027

Finalización del estudio (Estimado)

25 de noviembre de 2027

Fechas de registro del estudio

Enviado por primera vez

13 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data will not be made publicly available but can be shared with qualified researchers upon reasonable request to the principal investigator.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir